Importance of interdisciplinary collaboration regarding updated activated partial thromboplastin time reporting for heparin.
作者信息
Davis Sondra, Gutierrez Tiffany, Newcomer Darrell, Krishnan Rohini C
机构信息
Clinical Coordinator, Medical Center Arlington , Arlington, Texas.
Staff Pharmacist, Millwood Hospital , Arlington, Texas.
出版信息
Hosp Pharm. 2014 Jul;49(7):594-5. doi: 10.1310/hpj4907-594.
Abstract
摘要
相似文献
1
Importance of interdisciplinary collaboration regarding updated activated partial thromboplastin time reporting for heparin.关于肝素活化部分凝血活酶时间更新报告的跨学科协作的重要性。
Hosp Pharm. 2014 Jul;49(7):594-5. doi: 10.1310/hpj4907-594.
2
Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.活化部分凝血活酶时间是小儿体外膜肺氧合中更好的趋势工具。
Pediatr Crit Care Med. 2012 Nov;13(6):e363-71. doi: 10.1097/PCC.0b013e31825b582e.
3
Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.皮下注射普通肝素治疗深静脉血栓形成的最佳剂量
Thromb Res. 2000 Mar 15;97(6):395-403. doi: 10.1016/s0049-3848(99)00189-9.
4
Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.
Angiology. 2009 Jun-Jul;60(3):358-61. doi: 10.1177/0003319709332958. Epub 2009 Apr 26.
5
Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.全血凝固时间、活化部分凝血活酶时间和全血复钙时间作为肝素监测指标。
Am J Clin Pathol. 1979 Jan;71(1):17-21. doi: 10.1093/ajcp/71.1.17.
6
Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.抗因子 Xa 测定优于活化部分凝血活酶时间或活化凝血时间，是儿科体外膜肺氧合肝素剂量的更好相关指标*。
Pediatr Crit Care Med. 2014 Feb;15(2):e72-9. doi: 10.1097/PCC.0000000000000028.
7
Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.不稳定型冠状动脉疾病中凝血酶抑制后活化部分凝血活酶时间与临床结局
Eur Heart J. 1999 Nov;20(22):1657-66. doi: 10.1053/euhj.1999.1750.
8
The effect of heparin on the activated partial thromboplastin time.肝素对活化部分凝血活酶时间的影响。
Am J Clin Pathol. 1978 Sep;70(3 Suppl):556-9.
9
Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART Investigators.
J Am Coll Cardiol. 1992 Jul;20(1):31-5. doi: 10.1016/0735-1097(92)90133-8.
10
Design and Implementation of an Anti-Factor Xa Heparin Monitoring Protocol.抗 Xa 因子肝素监测方案的设计与实施。
AACN Adv Crit Care. 2020 Jun 15;31(2):129-137. doi: 10.4037/aacnacc2020132.
本文引用的文献
1
Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.肠外抗凝剂：抗血栓治疗与血栓预防，第 9 版：美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e24S-e43S. doi: 10.1378/chest.11-2291.
2
AACN standards for establishing and sustaining healthy work environments: a journey to excellence.美国危重症护理协会建立和维持健康工作环境的标准：卓越之旅
Am J Crit Care. 2005 May;14(3):187-97.
3
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.抗凝治疗指南：肝素：美国心脏协会给医疗专业人员的声明
Circulation. 2001 Jun 19;103(24):2994-3018. doi: 10.1161/01.cir.103.24.2994.
4
Establishing an institution-specific therapeutic range for heparin.建立特定机构的肝素治疗范围。
Am J Health Syst Pharm. 1998 Oct 1;55(19):2002-6. doi: 10.1093/ajhp/55.19.2002.
Zotero 插件